Use of a Thrombin Fibrin Sealant in Reducing Blood Loss in Revision Hip Arthroplasty

We present a retrospective evaluation assessing the use of a novel fibrin sealant, Quixil(®) (OMRIX Biopharmaceuticals S.A.) in reducing blood transfusions following revision total hip replacement surgery. Forty four patients underwent revision total hip replacement surgery using Quixil(®), while 45...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghoz, Ali, Al-Khateeb, Hesham, Rajkumar, Shanmugasundaram, Tavares, Shawn, Andrade, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645936/
https://www.ncbi.nlm.nih.gov/pubmed/27468998
http://dx.doi.org/10.2174/1874325001509010511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4645936/
https://www.ncbi.nlm.nih.gov/pubmed/27468998
http://dx.doi.org/10.2174/1874325001509010511

Ejemplares similares